Both in Medical Labs
Guardant Health vs Caris Life Sciences
Over the past year GH returned +76.9% and CAI returned +9.7%; their daily moves had a correlation of 0.43.
GH +76.9% CAI +9.7%Growth of $1, one year, split-adjusted
| Metric | GH | CAI |
|---|---|---|
| Price | $175.00 | $32.85 |
| Market cap | $23.48B | $9.28B |
| Today | +2.50% | +2.34% |
| 1 month | −6.5% | +8.1% |
| 6 months | +95.5% | +73.4% |
| Year to date | +71.3% | +21.8% |
| 1 year | +88.1% | +9.2% |
| Revenue growth (YoY) | +44.3% | +45.4% |
| Gross margin | 65.4% | 68.1% |
| Net margin | −35.9% | −0.2% |
| P/E (TTM) | — | 88.3× |
| Price / sales | 19.8× | 9.4× |
| Net cash | -$449.5M | $400.0M |
| Dividend yield | — | — |
| Volatility (60d) | 44.4% | 64.8% |
| Short % of float | 9.2% | 12.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).